Stay updated on SEA-CD70 Safety in Myeloid Malignancies Clinical Trial

Sign up to get notified when there's something new on the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The date has been updated from March 7, 2025, to March 11, 2025.
    Difference
    0.3%
    Check dated 2025-03-18T01:44:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has updated the reference to Seagen, clarifying its relationship as a subsidiary of Pfizer, and has changed the date from October 9, 2024, to March 7, 2025.
    Difference
    3%
    Check dated 2025-03-10T20:28:17.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T09:57:58.000Z thumbnail image
  5. Check
    33 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T01:47:43.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T00:57:39.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T12:14:48.000Z thumbnail image

Stay in the know with updates to SEA-CD70 Safety in Myeloid Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page.